Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work?

Similar documents
Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

1. Department of Ophthalmology, Pacific Medical College and Hospital, Udaipur, Rajasthan, India

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

Dry Eye Disease Update

Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

DRY EYE and MGD. Contact Central Maryland Eye Associates Today.

Optimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study

MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY?

Evidence for Technology in the Treatment of Advanced Dry Eye

Dry eye disease was recently redefined as a multifactorial

PROFILE OF MEIBOMIAN GLANDS IN MEIBOMIAN GLAND DYSFUNCTION

Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK)

Disposable Eyelid-Warming Device for the Treatment of Meibomian Gland Dysfunction

10/27/2017. Evidence for Technology in the Treatment of Dry Eye COPE: AS. Dry eye. Dry eye

ARTICLE COVERSHEET LWW_CONDENSED-FLA(8.125X10.875) SERVER-BASED

IPL for the management of MGD/DED. Dr. Jeffrey Judelson, FRCSC

T he meibomian glands secrete lipid into tears, and the lipid

Financial Disclosures

Consulting Bausch+Lomb/Valeant, NovaBay (Avenova), Google, Allergan, Vistakon, Alcon

Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction

Tear Structure. Structure = Stability. Disclosures. In Depth Management of Ocular Surface & Tear Film Disorders UNDERSTANDING THE OCULAR SURFACE

Meibomian gland Dropout in Chinese cataract patients.

Visionary Optics. SynergEyes. North Suburban Vision Consultants, Ltd. Keratoconus Specialists of Illinois. S. Barry Eiden, OD, FAAO

Microblepharoexfoliation for the Surgical Dry Eye Patient. Frank W. Bowden, III, M.D., FACS

Topical diquafosol for patients with obstructive meibomian gland dysfunction

The first comprehensive definition of DED was published in

A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction

Learn Connect Succeed. JCAHPO Regional Meetings 2017

Meibomian gland dysfunction

A DRY EYE DISEASE DECISION TREE

1/16/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.

Managing Dry Eye Disease

HELP HEAL YOUR PATIENTS DRY EYES.

9/26/ :00-10:00 Welcome, CE, breakfast, Tolosa 10:00 Head to Pismo Beach 10:30-12:30 2 hour workshop

Advanced Diagnosis and Management of OSD and Tear Dysfunction

pat hways Medtech innovation briefing Published: 21 April 2015 nice.org.uk/guidance/mib29

Ocular Jeopardy Marc R. Bloomenstein OD, FAAO

Dry eye, a common condition often manifested with visual

Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD

Pardon the Objection: Cases Marc R. Bloomenstein OD, FAAO Scot Morris, OD Derek Cunningham, OD Kathy Mastrota, OD

BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE

Dry Eye Syndrome (DES)

MANAGING THE LID MARGIN AND LASHES: IN-OFFICE PROCEDURES. Scott Schachter, OD Pismo Beach, CA

Scottish Dry Eye Guidelines

Evaluation of Dry Eye: A Hospital Based Study

World innovation for dry-eye syndrome using a new pulsed light technology: IRPL

MEIBOMIAN GLAND DYSFUNCTION: WHERE DRY EYE BEGINS

Ocular Surface Disease Workshop Walter O. Whitley, OD, MBA, FAAO Michael Cooper, OD Whitney Hauser, OD Scott Hauswirth, OD, FAAO

DRY EYE INFORMATION AND TREATMENTS

Prevalence of Dry Eye in Patients Presenting With Symptoms Suggestive of Dry Eye

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6

Meibomian gland dysfunction (MGD) is a chronic abnormality

Dry Eye. A Closer Look

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Evaluation of Tear Film Lipid Layer Thickness Measurements Obtained Using an Ocular Surface Interferometer in Nasolacrimal Duct Obstruction Patients

A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction


Prevalence of dry eye disease in type 2 diabetic patients and its co-relation with the duration, glycemic control and retinopathy

D RY E YE C LINIC AT THE O FFICE OF D R. D AVID R. F RAZEE

RECENT ADVANCES IN THE MANAGEMENT AND TREATMENT OF DRY EYE DISEASE

Correlation of Bacterial Burden, Meibomian Gland Dysfunction and Ocular Surface Disease

Tear Osmolarity and its role in Optometric Practice & Contact Lens Success

1/23/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.

JMSCR Vol 05 Issue 02 Page February 2017

World innovation for dry-eye syndrome using Intense Pulsed Light technology

Conjunctivochalasis (Cch) is described as lax and redundant. The Impact of Conjunctivochalasis on Dry Eye Symptoms and Signs

Dry Eye Prescribing Guidelines

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM

Objective image analysis of the meibomian gland area

9/26/2018 MANAGING THE LID MARGIN AND LASHES: IN-OFFICE PROCEDURES WHY OFFER IN-OFFICE PROCEDURES WHY OFFER IN-OFFICE PROCEDURES DISCLOSURES

Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402

OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY

Blepharitis. Information for patients Ophthalmology (Emergency Eye Centre) Large Print

A Clinical Study of Meibomian Gland Dysfunction in Patients with Diabetes in Bundelkhand region

Meibomian gland dysfunction (MGD) may well be the leading

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...

Ocular Surface Disease. Advanced Treatment in Ocular Surface Disease. Disclosures. Revenue Potential. Chronic Dry Eye Should I Treat It

Agreement in dry eye management between optometrists and general practitioners in primary health care in the Netherlands

A Non-Randomised, Patient Completed Questionnaire Report.

Dry Eye Disease (DED)

& Treatment Strategy. for Dry Eye Associated With MGD. A Diagnostic. December Published as a supplement to. INHERENTLY DIFFERENT See how

Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness

The International Workshop on Meibomian Gland Dysfunction: Report of the Clinical Trials Subcommittee

MANAGING THE LID MARGIN AND LASHES: IN-OFFICE PROCEDURES. Scott Schachter, OD Pismo Beach, CA

In Vivo Confocal Microscopy of Meibomian Glands in Sjögren s Syndrome

Spontaneous Eye Blink Patterns in Dry Eye: Clinical Correlations

A Systematic Approach to Dry Eye using LipiFlow Treatment. Mitchell A Jackson, MD. Founder/CEO, Jacksoneye, Lake Villa, Illinois, US

Incidence of dry eye in a sample population in Kuala Lumpur

Prospective Trial of Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction

Dry Eye Syndrome Prescribing Guidelines

PRESUMED HYPOSECRETORY/HYPEREVAPORATIVE KCS: TEAR CHARACTERISTICS

The Tear Film! Cataract Surgery in the Diseased Eye: Ocular Surface Disease

Symptom Burden of Patients with Dry Eye Disease: A Four Domain Analysis

No Conflict of Interest to Report Charles Stockwell, O.D

1998 DESCRIPTION Evaluation of Subjective and Objective tests for diagnosing tear-film disorders known to cause ocular irritation.

Dry Eyes The mucin layer

Efficacy and Safety of Diquafosol Ophthalmic Solution in Patients with Dry Eye Syndrome: A Japanese Phase 2 Clinical Trial

Transcription:

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/282816021 Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work? Conference Paper October 2015 READS 30 2 authors: Leslie E. O'Dell Salus University 15 PUBLICATIONS 2 CITATIONS Milton M Hom Independent Researcher 62 PUBLICATIONS 536 CITATIONS SEE PROFILE SEE PROFILE Available from: Milton M Hom Retrieved on: 25 May 2016

Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work? Leslie O Dell, OD, FAAO Milton M. Hom, OD, FAAO S

Disclosures Unsponsored research S

Purpose S Does in-office manual expression improve symptoms for patients with MGD? S Does in-office manual expression improve MG function for patients with MGD?

Meibomian Gland Dysfuntion Nichols KK, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52(4): 1922-1929.

MGD S Meibomian Gland Dysfunction (MGD) is the most common cause of dry eye 1-4 1. Goto E, Monden Y, Takano Y, et al. Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compress device. Br J Ophthalmol 2002;86:1403-1407. 2. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7(2 Suppl):S1-S14. 3. Lemp MA, Crews LA, Bron AJ, et al. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472-8. 4. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995;113(10):1266-1270. 1

Manual Expression S Forced expression has been a treatment for obstructed glands dating back to 1888 5 S Manual expression of the MG is proven to be an effective treatment 6 however is widely underutilized 7 5. Duke-Elder WS, MacFaul PA. The ocular adnexa, part II, diseases of eyelids. IN: System of Ophthalmology. London, United Kingdom, H. Kimpton, 1974, v. XIII, pp242. 6. Korb DR. Greiner JV. Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. Adv Exp Med Biol 1994;350:293-298. 7. Blackie CA, Kor DR. Meibomian gland expression: Forces of Expression, types of secretion and the limitation of resulting pain. Invest Ophthalmol Vis Sci 2010;3385/D971.

Methods S Single site evaluation of the effectiveness of manual expression on MG function and symptom relief S N=24 subjects: S M:F 6:18 S Mean age 63.5 years old (37 to 81 years).

Methods S Inclusion criteria: S >18 years S Self reported dry eye S H/o chronic MGD S Consent to treatment with manual expression S Exclusion criteria: S Active inflammation/infection S Ocular surgery within 3 months S Contact lens use S Symptoms were evaluated using OSDI and SPEED validated questionnaires - Baseline/2 weeks/1 month

OSDI S S S Validated, used to diagnose any type of DED 12-item questionnaire S Graded 0-4 Scoring S 0-100* (Schiffman et al, Arch Ophthalmol 2000) S Dry if score > 12* (Miller et al, Arch Ophthalmol, 2010 )

SPEED Patient Name: RIGHT EYE S Validated Date: DRY EYE QUESTIONNAIRE - SPEED LEFT EYE Please answer the following questions by checking the box that best represents your answer. Select only one answer per question. S Evaluates frequency and duration of symptoms S Scored 0-28 S Mild dry eye 5 S Moderate dry eye =6-9 S Severe dry eye 10 1. Report the type of SYMPTOMS you experience and when they occur: WITHIN PAST WITHIN PAST AT THIS VISIT SYMPTOMS 72 HRS 3 MONTHS YES NO YES NO YES NO Dryness, Grittiness or Scratchiness Soreness or Irritation Burning or Watering Eye Fatigue 2. Report the FREQUENCY of your symptoms using the rating list below: SYMPTOMS 0 1 2 3 Dryness, Grittiness or Scratchiness Soreness or Irritation Burning or Watering Eye Fatigue 0 = Never 1 = Sometimes = Often = Constant 2 3 3. Report the SEVERITY of your symptoms using the rating list below: SYMPTOMS 0 1 2 3 4 Dryness, Grittiness or Scratchiness Soreness or Irritation Burning or Watering Eye Fatigue 0 = No problems 1 = Tolerable not perfect but not uncomfortable 2 = Uncomfortable irritating but does not interfere with my day 3 = Bothersome irritating and interferes with my day 4 = Intolerable unable to perform my daily tasks use eye drops for lubrication? YES NO If yes, how often? 4. Do you Korb DR, Blackie CA, Meibomian Gland Diagnostic Expressibility: Correlation with Dry Eye Symptoms and Gland Location. Cornea. 2008 Vol 27; 10: 1142-1147.

Methods S Gland function was assessed using Meibomian Gland (MG) secretion score S Meibomian Glands Yeilding Liquid Secretion (MGYLS) S Grading 15 meibomian glands of the lower eyelid S Scale of 0-45 where 45=normal Grade Quality of MG secretion 0 No secretion 1 Inspissated 2 Liquid colored 3 Clear oil

Warming the lids S External heat was applied to both eyes using commercially available eyelid warming mask for 10 minutes prior to expression S (From the report of Murakami et al OVS (2015), this approach is effective is raising internal eyelid temperature for an effective treatment time (> 4 minutes))

Methods S Manual expression performed on one eye S Performed on both upper and lower lids immediately following heat therapy S Glands expressed distal to proximal nasal to temporal S Glands were expressed for 10-15 secs

Expressing the glands S Manual expression one eye at the slit lamp with Maskin Meibum Expressor (Rhein medical) S Expressed glands distal to proximal for both upper and lower lids

Results Significance was found in symptom relief using both SPEED an OSDI S

Subjective improvement with SPEED 18 16 14 12 10 8 6 4 2 0 16.08 12.24 11.16 9.2 10.16 7.76 Baseline 2 weeks 1 month Treated eye Untreated Eye

Subjective improvement with SPEED 28 26 24 22 20 18 16 14 12 10 8 6 4 2 0 16.08 Test eye change from baseline: 2 weeks p=0.004 and 1 month p<0.0001 9.2 Baseline 2 weeks 1 month 7.76

Subjective improvement- OSDI 70 60 50 40 30 20 Statistically significant change from baseline in treated group at 2 week and 1 month, no significant change from baseline in control Treated Eye Untreated Eye 10 0 Baseline 2 weeks 1 month

Objective findings MG secretion score 45 40 35 30 25 20 15 10 5 0 Baseline 2 week 1 month treated eye untreated eye

Conclusions S

Conclusions S One time manual expression using forceps shows significant improvement in symptoms at two weeks and one month when compared to the control eyes S Symptoms improve with manual expression despite no improvement in objective MGD scores

Technique considerations S Heat each eye individually prior to expression to maintain liquefaction of meibum S Pain associated with manual expression S Potential for MG loss with manual expression??

LEO- Liquefy, Express, Observe In-office manual expression LEO: Liquefy, Express, Observe Version 2.4 9.16.15 Please check with us for permission if you want to publish Corresponding author: Leslie O Dell email: leslieod@hotmail.com!! Pre%treatment!! 1. Confirm!Meibomian!Gland!(MG)!Obstruction! addressing!4!components!of!mg!dysfunction!(mgd)! a. Meibum!Composition%!Evaluate!the!MG! secretions!using!finger!compression!or!cotton!bud!to! press!on!the!outer!portion!of!the!lower!lid!margin.!! Additionally,!meibomian!gland!evaluator!could!be! used!to!assess!the!quality!of!meibum.! b. Terminal!duct!and!MG!orifice!obstruction!! c. Inflammatory!load!generated!by!primary!or!

Thank You lodell@dryeyecenterofpa.com S